Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombolytic therapy for acute ischemic stroke

E C Haley1

  • 1Department of Neurology, University of Virginia Health Sciences Center, Charlottesville 22908.

Clinical Neuropharmacology
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lack of clinical significance of early ischemic changes on computed tomography in acute stroke.

JAMA·2001
Same author

Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke.

Annals of neurology·2001
Same author

Correlation of aphasia and/or neglect with cortical infarction in a subpopulation of RANTTAS.

Cerebrovascular diseases (Basel, Switzerland)·2001
Same author

Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial.

JAMA·2001
Same author

Postischemic attenuation of cerebral artery reactivity is increased in the presence of tissue plasminogen activator.

Stroke·2001
Same author

Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study.

Neurology·2000

Emergency treatment for acute thromboembolic stroke using clot-busting drugs is gaining traction. Early recanalization of cerebral arteries shows promise, but definitive proof of long-term clinical benefit requires further study.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Emergency Medicine

Background:

  • Acute thromboembolic stroke treatment is evolving.
  • Thrombolytic therapy for stroke was previously considered unsafe.
  • Recent advancements have renewed interest in this approach.

Purpose of the Study:

  • To explore the efficacy and safety of emergency thrombolytic treatment for acute thromboembolic stroke.
  • To evaluate the potential for early recanalization of cerebral arteries.

Main Methods:

  • Review of recent clinical and laboratory studies on thrombolytic agents.
  • Analysis of outcomes using local arterial or intravenous thrombolytic administration.
  • Assessment of risks associated with early recanalization.

Related Experiment Videos

Main Results:

  • Emerging evidence suggests very early recanalization of cerebral arteries is achievable.
  • Thrombolytic therapy can be administered with acceptable risks.
  • Published reports indicate potential clinical benefits.

Conclusions:

  • Emergency thrombolytic treatment for acute stroke is a developing field.
  • Further research is needed to establish definitive proof of sustained clinical efficacy.
  • Comparative studies with concurrent controls are required to confirm functional outcomes.